Cargando…
Post hoc analysis examining symptom severity reduction and symptom absence during food challenges in individuals who underwent oral immunotherapy for peanut allergy: results from three trials
PURPOSE: Peanut allergy and its current management, involving peanut avoidance and use of rescue medication during instances of accidental exposure, are burdensome to patients and their caregivers and can be a source of stress, uncertainty, and restriction. Physicians may also be frustrated with a l...
Autores principales: | Blumchen, Katharina, Kleinheinz, Andreas, Klimek, Ludger, Beyer, Kirsten, Anagnostou, Aikaterini, Vogelberg, Christian, Butovas, Sergejus, Ryan, Robert, Norval, David, Zeitler, Stefan, Du Toit, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009988/ https://www.ncbi.nlm.nih.gov/pubmed/36915184 http://dx.doi.org/10.1186/s13223-023-00757-8 |
Ejemplares similares
-
White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
por: Lange, Lars, et al.
Publicado: (2021) -
Local Neuronal Responses to Intracortical Microstimulation in Rats' Barrel Cortex Are Dependent on Behavioral Context
por: Butovas, Sergejus, et al.
Publicado: (2022) -
Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written
por: Klimek, Ludger, et al.
Publicado: (2015) -
Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013) -
Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
por: Fernandez‐Rivas, Montserrat, et al.
Publicado: (2021)